May 2, 2017 / 12:52 PM / 3 months ago

BRIEF-Oramed receives Israel regulatory approval

1 Min Read

May 2 (Reuters) - Oramed Pharmaceuticals Inc:

* Oramed receives Israel regulatory approval to conduct human study for new oral leptin capsule

* Oramed Pharmaceuticals-Israel's ministry of health approved Oramed's commencement of proof of concept single dose study for its oral leptin drug candidate Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below